18-40 GHz High Frequency Power Amplifier
SOL #: 75F40126Q133599Combined Synopsis/Solicitation
Overview
Buyer
Health And Human Services
Food And Drug Administration
FDA OFFICE OF ACQ GRANT SVCS
Rockville, MD, 20852, United States
Place of Performance
Silver Spring, MD
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
PSC
Laboratory Equipment And Supplies (6640)
Set Aside
Total Small Business Set-Aside (FAR 19.5) (SBA)
Original Source
Timeline
1
Posted
Jun 11, 2026
2
Submission Deadline
Jun 18, 2026, 6:00 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), has issued a Combined Synopsis/Solicitation (RFQ) for a High Frequency Power Amplifier (18-40 GHz). This amplifier is required for regulatory science research concerning the safety of medical devices exposed to electromagnetic emitters. This opportunity is a Total Small Business Set-Aside. Quotes are due by June 18, 2026, at 1:00 PM Central Time.
Scope of Work
The requirement is for one (1) High Frequency Power Amplifier with specific technical requirements, including:
- Operating Frequency Range: 18–40 GHz
- Output Power: ≥ 20 W
- Small Signal Gain: ≥ 43 dB
- Technology: Solid-state, standalone unit with integrated control, power supply, and cooling.
- Capabilities: Must amplify both continuous wave (CW) and modulated signals, include infinite load protection, and operate stably.
- Connectivity: RF input via 2.92mm K-connectors, RF output via WRD 180 waveguide (includes adaptor to WD28 for 26-40 GHz range).
- Control: Remotely controllable via USB or Ethernet, with direct or computer-based readout of output power.
- Warranty: At least one year from instrument acceptance. Optional items include two (2) Phase-Stable Cable Assemblies and one (1) Waveguide to Coaxial Adapter.
Contract & Timeline
- Contract Type: Firm-Fixed Price
- Set-Aside: Total Small Business (NAICS 334516, Small Business Size Standard: 1,000 employees)
- Quote Due Date: June 18, 2026, 1:00 PM Central Time
- Published Date: June 11, 2026
- Period of Acceptance: Prices firm through September 30, 2026
Submission & Evaluation
- Submission Method: Via e-Mail to howard.nesmith@fda.hhs.gov, referencing solicitation number 75F40126Q133599.
- Evaluation Criteria: Award will be made to the Lowest Price Technically Acceptable (LPTA) and responsible offeror. Evaluation will prioritize price, followed by technical acceptability.
- Technical Acceptability: Offerors must provide sufficient descriptive material to demonstrate compliance with all technical requirements.
- Eligibility: Offerors must be registered and active in SAM.gov and include their Unique Entity Identifier (UEI) with the quotation. Submissions must not contain macros.
Additional Notes
- Place of Performance/Delivery: FOB Destination to U.S. Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, MD 20993. Price quotes must be inclusive of all shipping, handling, and delivery charges.
- Accessibility: Offerors must comply with HHS Section 508 accessibility standards and submit an Accessibility Conformance Report (ACR) or HHS Section 508 Accessibility Conformance Checklist.
- Payment Terms: Net 30 Days After Government Acceptance, with invoices submitted via the U.S. Department of Treasury's Invoice Processing Platform (IPP).
People
Points of Contact
Howard NesmithPRIMARY
Files
Files
Versions
Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 11, 2026